Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis

Owing to the high risk of recurrence, identifying indicators of carotid plaque vulnerability in atherothrombotic ischemic stroke is essential. In this study, we aimed to identify modified LDLs and antioxidant enzymes associated with plaque vulnerability in plasma from patients with a recent ischemic stroke and carotid atherosclerosis. Patients underwent an ultrasound, a CT-angiography, and an 18F-FDG PET. A blood sample was obtained from patients (n = 64, 57.8% with stenosis ≥50%) and healthy controls (n = 24). Compared to the controls, patients showed lower levels of total cholesterol, LDL cholesterol, HDL cholesterol, apolipoprotein B (apoB), apoA-I, apoA-II, and apoE, and higher levels of apoJ. Patients showed lower platelet-activating factor acetylhydrolase (PAF-AH) and paraoxonase-1 (PON-1) enzymatic activities in HDL, and higher plasma levels of oxidized LDL (oxLDL) and electronegative LDL (LDL(−)). The only difference between patients with stenosis ≥50% and <50% was the proportion of LDL(−). In a multivariable logistic regression analysis, the levels of LDL(−), but not of oxLDL, were independently associated with the degree of carotid stenosis (OR: 5.40, CI: 1.15–25.44, p < 0.033), the presence of hypoechoic plaque (OR: 7.52, CI: 1.26–44.83, p < 0.027), and of diffuse neovessels (OR: 10.77, CI: 1.21–95.93, p < 0.033), indicating that an increased proportion of LDL(−) is associated with vulnerable atherosclerotic plaque.

[1]  J. Martí-Fàbregas,et al.  Serum from Stroke Patients with High-Grade Carotid Stenosis Promotes Cyclooxygenase-Dependent Endothelial Dysfunction in Non-ischemic Mice Carotid Arteries. , 2022, Translational stroke research.

[2]  J. Polak,et al.  Interleukin-6 Predicts Carotid Plaque Severity, Vulnerability, and Progression , 2022, Circulation research.

[3]  J. Martí-Fàbregas,et al.  Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke , 2022, Translational Stroke Research.

[4]  Hao Li,et al.  Inverse Association between High-Density Lipoprotein Cholesterol and Adverse Outcomes among Acute Ischemic Stroke Patients with Diabetes Mellitus , 2021, Biomedicines.

[5]  F. Crea,et al.  Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events. , 2021, European heart journal.

[6]  I. van Herzeele,et al.  European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis , 2021, European stroke journal.

[7]  M. Fitó,et al.  Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo , 2020, Biomedicines.

[8]  F. Jiménez-Altayó,et al.  Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages , 2020, Cells.

[9]  Yilong Wang,et al.  Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA. , 2020, Atherosclerosis.

[10]  R. Delgado-Mederos,et al.  Plaque neovascularization detected with contrast‐enhanced ultrasound predicts ischaemic stroke recurrence in patients with carotid atherosclerosis , 2020, European journal of neurology.

[11]  J. Harbison,et al.  Carotid Plaque Inflammation Imaged by 18F-Fluorodeoxyglucose Positron Emission Tomography and Risk of Early Recurrent Stroke. , 2019, Stroke.

[12]  T. Hsieh,et al.  Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients , 2019, Journal of clinical medicine.

[13]  F. Mannello,et al.  Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: Inhibitory effect of glycosaminoglycan sulodexide. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[14]  R. Dixon,et al.  Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo , 2018, Aging cell.

[15]  S. Larsson,et al.  Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes , 2018, Stroke.

[16]  M. Baumann,et al.  Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties. , 2017, The American journal of pathology.

[17]  Tzu-Ching Yang,et al.  L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages. , 2017, American journal of physiology. Heart and circulatory physiology.

[18]  W. Lai,et al.  Four Statin Benefit Groups Defined by The 2013 ACC/AHA New Cholesterol Guideline are Characterized by Increased Plasma Level of Electronegative Low-Density Lipoprotein. , 2016, Acta Cardiologica Sinica.

[19]  Jia-Rong Wu,et al.  Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. , 2016, Blood.

[20]  T. Sawamura,et al.  Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis , 2016, Medicine.

[21]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[22]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[23]  J. L. Sánchez-Quesada,et al.  Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation , 2013, Mediators of inflammation.

[24]  Antonio Pérez,et al.  Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes , 2013, Cardiovascular Diabetology.

[25]  J. Obata,et al.  Contrast-enhanced ultrasound imaging of carotid plaque neovascularization is useful for identifying high-risk patients with coronary artery disease. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[26]  Dolores Corella,et al.  A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among High-Risk Subjects: The PREDIMED Trial , 2012, PloS one.

[27]  Manfred Kaps,et al.  Grading carotid stenosis using ultrasonic methods. , 2012, Stroke.

[28]  Y. Uehara,et al.  Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study , 2009, Journal of Lipid Research.

[29]  D. Rader,et al.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008. , 2009, Journal of Lipid Research.

[30]  A. Burns,et al.  Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1: A Possible Mechanism of Endothelial Apoptosis , 2009, Circulation research.

[31]  Jie Du,et al.  Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. , 2007, Endocrinology.

[32]  K. Ha,et al.  Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. , 2006, American journal of physiology. Heart and circulatory physiology.

[33]  P. Touboul,et al.  Blood Lipids in Brain Infarction Subtypes , 2006, Cerebrovascular Diseases.

[34]  A. Kontush,et al.  Antiatherogenic small, dense HDL—guardian angel of the arterial wall? , 2006, Nature Clinical Practice Cardiovascular Medicine.

[35]  P. Rothwell.  ACST: which subgroups will benefit most from carotid endarterectomy? , 2004, The Lancet.

[36]  J. Ordóñez‐Llanos,et al.  Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential , 2004, Circulation research.

[37]  J. López-Miranda,et al.  Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. , 2004, The American journal of cardiology.

[38]  J. Ordóñez‐Llanos,et al.  Platelet‐Activating Factor Acetylhydrolase Is Mainly Associated With Electronegative Low‐Density Lipoprotein Subfraction , 2003, Circulation.

[39]  J. Ordóñez‐Llanos,et al.  Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells. , 2003, Atherosclerosis.

[40]  H. Horiguchi,et al.  Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[41]  D. Shih,et al.  HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  J. Ordóñez‐Llanos,et al.  Electronegative LDL From Normolipemic Subjects Induces IL-8 and Monocyte Chemotactic Protein Secretion by Human Endothelial Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[43]  M. Pratt,et al.  Effectiveness of physician-based assessment and counseling for exercise in a staff model HMO. , 2000, Preventive medicine.

[44]  H. Kleinman,et al.  Angiogenic activity of human soluble intercellular adhesion molecule-1. , 1999, Cancer research.

[45]  G. Fonarow,et al.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. , 1997, The Journal of clinical investigation.

[46]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[47]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[48]  A. Nicolaides,et al.  Characterization of symptomatic and asymptomatic carotid plaques using high‐resolution real‐time ultrasonography , 1993, The British journal of surgery.

[49]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[50]  Yilong Wang,et al.  Association of Oxidized Low-Density Lipoprotein With Prognosis of Stroke and Stroke Subtypes , 2017, Stroke.

[51]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[52]  T. Akasaka,et al.  Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease. , 2013, European heart journal cardiovascular Imaging.

[53]  A. Fox,et al.  Quantification of carotid stenosis on CT angiography. , 2006, AJNR. American journal of neuroradiology.

[54]  P. Durrington,et al.  The Role of Paraoxonase 1 Activity in Cardiovascular Disease , 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[55]  J. Ordóñez‐Llanos,et al.  Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. , 2002, Atherosclerosis.